CCI
SGMO

Columbus Circle Investors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Columbus Circle Investors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-355,167
Closed -$1.85M – 288
2017
Q1 		$1.85M Sell
355,167
-85,261
-19% -$342K 0.03% 222
2016
Q4 		$1.34M Sell
440,428
-76,069
-15% -$277K 0.02% 228
2016
Q3 		$2.39M Buy
516,497
+223,014
+76% +$1.13M 0.03% 228
2016
Q2 		$1.7M Buy
293,483
+151,487
+107% +$965K 0.02% 214
2016
Q1 		$859K Sell
141,996
-435,197
-75% -$2.61M 0.01% 244
2015
Q4 		$5.27M Sell
577,193
-174,881
-23% -$1.35M 0.04% 223
2015
Q3 		$4.24M Sell
752,074
-25,991
-3% -$214K 0.03% 228
2015
Q2 		$8.63M Buy
778,065
+342,676
+79% +$4.42M 0.06% 216
2015
Q1 		$6.83M Buy
435,389
+270,321
+164% +$4.18M 0.05% 228
2014
Q4 		$2.51M Buy
+165,068
New +$2M 0.02% 241

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Columbus Circle Investors's SGMO Position: Q2 2017 in Review

Columbus Circle Investors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2017, closing a stake of 355,167 shares — an estimated $1.85M sold.

Columbus Circle Investors first reported a position in SGMO in Q4 2014 and held it in 10 quarters. The position peaked at $8.63M in Q2 2015. 143 funds tracked by Wall St. Rank hold SGMO as of Q2 2017.

  • Columbus Circle Investors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 355,167 SANGAMO THERAPEUTICS INC shares in Q2 2017, an estimated $1.85M.
  • Columbus Circle Investors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 10 quarters.
  • Columbus Circle Investors's SANGAMO THERAPEUTICS INC position peaked at $8.63M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2017.

Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.